General Atlantic LLC Karuna Therapeutics, Inc. Transaction History

General Atlantic LLC

  • $3.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$164.66 - $218.08 $42.8 Million - $56.6 Million
259,752 Added 35.73%
986,710 $167 Million
Q2 2023

Aug 11, 2023
BUY
$176.32 - $240.22 $1.9 Million - $2.59 Million
10,800 Added 1.51%
726,958 $158 Million
Q4 2022

Feb 14, 2023
BUY
$191.53 - $236.82 $57.7 Million - $71.3 Million
301,158 Added 72.57%
716,158 $141 Million
Q3 2022

Nov 14, 2022
BUY
$123.79 - $277.42 $51.4 Million - $115 Million
415,000 New
415,000 $93.3 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track General Atlantic LLC Portfolio

Follow General Atlantic LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Atlantic LLC, based on Form 13F filings with the SEC.

News

Stay updated on General Atlantic LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email